CEO Dan O'Day, tasked with boosting Gilead's oncology presence, scores $19M for a year focused ...

Retrieved on: 2021-04-05 15:40:26

Tags for this article:

Click the tags to see associated articles and topics

CEO Dan O'Day, tasked with boosting Gilead's oncology presence, scores $19M for a year focused .... View article details on hiswai:

Excerpt

O'Day, a veteran of oncology giant Roche, joined the California drugmaker in March 2019. When the company named him CEO in late 2018, it had ...

Article found on: www.fiercepharma.com